EHC vs ENSG stock comparison
Encompass Health vs. Ensign Group · data as of November 13, 2026
Encompass Health (EHC) has a market value of about $13.8B, Ensign Group (ENSG) about $11.0B. Over their latest twelve months Encompass Health had revenue of $6.3B and Ensign Group $5.7B.
On our five checks Encompass Health scores higher: 3.6 out of 5 (good) against 2.6 (average).
By area, the stronger company is Encompass Health on value; Encompass Health on future growth; Encompass Health on track record; Encompass Health on shareholder returns.
Encompass Health is cheaper on earnings (P/E 22.0 vs. 28.0), while Ensign Group grew revenue faster over five years (16.1% vs. 10.7% a year).
Encompass Health leads on 18 of the compared lines and Ensign Group on 5.
Side by side
| EHC | ENSG | |
|---|---|---|
| Size and price | ||
| Market cap | $13.8B | $11.0B |
| Share price | $140.99 | $188.41 |
| Score | ||
| Overall score (of 5) | 3.6 | 2.6 |
| Value | 2 | 0 |
| Future growth | 4 | 3 |
| Track record | 5 | 4 |
| Financial health | 3 | 3 |
| Shareholder returns | 4 | 3 |
| Valuation | ||
| P/E (TTM) | 22.0 | 28.0 |
| Forward P/E | 20.9 | 21.7 |
| Price / free cash flow | 30.3 | 52.3 |
| Price / sales | 2.2 | 1.9 |
| EV / EBITDA | 10.7 | 20.5 |
| PEG | 1.55 | 2.03 |
| DCF value vs. price | −46% | −51% |
| Business | ||
| Revenue | $6.3B | $5.7B |
| Net income | $644M | $399M |
| Free cash flow | $457M | $210M |
| Net margin | 10.2% | 7.0% |
| Gross margin (5-yr avg.) | — | 21.5% |
| ROIC (5-yr avg.) | 12.2% | 7.4% |
| Growth | ||
| Revenue growth (1 yr) | 10.5% | 18.7% |
| Revenue growth (5 yrs, per year) | 10.7% | 16.1% |
| EPS growth (5 yrs, per year) | 14.2% | 13.8% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$2.7B | -$1.9B |
| Dividend yield | 0.60% | 0.14% |
| Shareholder yield | 1.7% | 0.3% |
| Analysts | ||
| Upside to average target | +11% | +20% |
| Consensus rating | Strong buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: EHC TTM to September 30, 2026, ENSG TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Encompass Health or Ensign Group?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Encompass Health scores 3.6 out of 5 and Ensign Group 2.6; the table shows where each one is stronger.
Is Encompass Health cheaper than Ensign Group?
On trailing earnings, Encompass Health trades at a P/E of 22.0 and Ensign Group at 28.0, so Encompass Health is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Encompass Health or Ensign Group?
Over five years Ensign Group grew revenue about 16.1% a year and Encompass Health about 10.7% a year.
Which pays a higher dividend?
Encompass Health yields 0.60% and Ensign Group 0.14%.
Full Encompass Health analysis → Full Ensign Group analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.